G Medical Innovations Holdings Ltd
OTC:GMVDF
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| KY |
G
|
G Medical Innovations Holdings Ltd
OTC:GMVDF
|
26k USD |
Loading...
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
96.8B USD |
Loading...
|
|
| US |
|
Cigna Corp
NYSE:CI
|
75.3B USD |
Loading...
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
63.5B EUR |
Loading...
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
27.7B EUR |
Loading...
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.9B EUR |
Loading...
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
23.1B USD |
Loading...
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.3B USD |
Loading...
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.7B EUR |
Loading...
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
12.6B USD |
Loading...
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
10.6B USD |
Loading...
|
Market Distribution
| Min | -9 935.2% |
| 30th Percentile | -5.8% |
| Median | -0.3% |
| 70th Percentile | 6.5% |
| Max | 36.5% |
Other Profitability Ratios
G Medical Innovations Holdings Ltd
Glance View
G Medical Innovations Holdings Ltd. engages in the development of mobile and e-health solutions and monitoring service platforms. The company is headquartered in George Town, Grand Cayman. The company went IPO on 2017-10-26. The company is developing the mobile technologies and services that are designed to allow consumers, patients and providers to monitor, manage and improve clinical and personal health outcomes. Its products consist of Prizma medical device (Prizma), a clinical grade device that can transform any smartphone into a medical monitoring device; Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography (ECG) data including QT Syndrome Prolongation Detection Capabilities Patch. The company is also developing Wireless Vital Signs Monitoring System (VSMS), which will provide real time monitoring of vital signs and biometrics. Its monitoring services include provision of Independent Diagnostic Testing Facility (IDTF) monitoring services and private monitoring services.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
Over the last 3 years, G Medical Innovations Holdings Ltd’s Net Margin has increased from -1 245% to -160.5%. During this period, it reached a low of -1 245% on May 30, 2018 and a high of -160.5% on Jul 30, 2021.
